From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA, manufacturers seek safer pain medications


One main goal of the FDA's Opioid Action Plan is to support the development of less dangerous pain medicines, including generic versions of therapies with anti-abuse features. With reports of thousands of opioid-related deaths a year, biopharmaceutical manufacturers are investing in promising nonopioid compounds and other innovations able to manage chronic and acute pain more safely. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063